Comparative clinical and economic assessment of polatuzumab vedotin therapy in combination with bendamustine and rituximab for adult transplantation-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma

I. N. Dyakov; K. K. Bushkova

Oncohematology
Onkogematologiâ

ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)

User

eng | рус

Oncohematology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Dyakov I.N., Bushkova K.K. Comparative clinical and economic assessment of polatuzumab vedotin therapy in combination with bendamustine and rituximab for adult transplantation-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma. Oncohematology. 2022;17(3):160-170. (In Russ.) https://doi.org/10.17650/1818-8346-2022-17-3-160-170

Views PDF (Rus): 424

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Pervin A. Zeynalova

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Notifications

About the Authors

I. N. Dyakov
Scientific and Practical Center for Rational Pharmacotherapy and Pharmacoeconomics Problems; I.I. Mechnikov Research Institute of Vaccines and Serums; The Gamaleya National Center of Epidemiology and Microbiology
Russian Federation

Ilya N. Dyakov.

Build. 1, 12 Pod'emnaya St., Moscow 109052; 5a Malyy Kazennyy Pereulok, Moscow 105064; 18 Gamalei St., Moscow 123098.

K. K. Bushkova
Scientific and Practical Center for Rational Pharmacotherapy and Pharmacoeconomics Problems; I.I. Mechnikov Research Institute of Vaccines and Serums
Russian Federation

Build. 1, 12 Pod'emnaya St., Moscow 109052; 5a Malyy Kazennyy Pereulok, Moscow 105064.

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Oncohematology

For citations:

Cookies policy